Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Immun Inflamm Dis ; 9(3): 681-693, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-34061447

RESUMEN

INTRODUCTION: Overexpressed inflammatory cytokines are the main factors causing rheumatoid arthritis (RA) tissue damage and pathological deterioration, and lncRNAs has found to beinvolved in some autoinflammatory diseases. METHODS: We designed this study to investigate the effect of lncRNA linc00152 on rheumatoid arthritis inflammation and explore its molecular mechanism. RESULT: We found that linc00152 was not only up-regulated in rheumatoid arthritis fibroblast-like synoviocytes (RAFLS), but also stimulated by TNF-α/IL-1ß in adose- and time-dependent manner in RAFLS and this expression depends on the NF-κB signaling pathway. Conversely, linc00152 promoted TNF-α/IL-1ß expression in RAFLS induced by TNF-α/IL-1ß. In addition, we found that linc00152 promoted TAK1 expression by targeting inhibition of miR-103a and activated TAK1-mediated NF-κB pathway. NF-kB indirectly promotes linc00152 expression by promoting the transcription activity of YY1, and YY1 directly promotes linc00152 expression by binding the promoter of linc00152. CONCLUSION: Our data suggested that the linc00152/NF-κB feedback loop promotes RAFLS inflammation via regulating miR-103a/TAK1 axis and YY1 expression. Thus, linc00152 acts as a switch to control this regulatory circuit and may serve as a diagnostic and therapeutic target for RA treatment.


Asunto(s)
Artritis Reumatoide , MicroARNs , ARN Largo no Codificante , Sinoviocitos , Artritis Reumatoide/genética , Retroalimentación , Fibroblastos , Humanos , Inflamación/genética , MicroARNs/genética , ARN Largo no Codificante/genética , Factor de Transcripción YY1/genética
2.
J Pain Res ; 13: 2653-2662, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33116807

RESUMEN

PURPOSE: To investigate the effectiveness of moxibustion at different times of the menstrual cycle for patients with primary dysmenorrhea (PD). PATIENTS AND METHODS: Participants were 208 patients allocated to three controlled groups: one pre-menstrual treatment group (Group A), one menstrual-onset treatment group (Group B), and one waiting-list group (Group C). Groups A and B received the same intervention of moxibustion on points SP6 and RN4 but at different times. Group C, the waiting-list group, received no treatment throughout the study. Cox Menstrual Symptom Scale (CMSS) score was the primary outcome. Secondary outcomes were visual analog scale (VAS) score of pain intensity, self-rating anxiety scale (SAS) score, and self-rating depression scale (SDS) score. CMSS and VAS scores were obtained at the baseline stage (three cycles), treatment stage (three cycles), and follow-up stage (three cycles), a total of seven evaluations. SAS and SDS scores were obtained on the day of group allocation and the first day of the follow-up stage, a total of two evaluations. RESULTS: Baseline characteristics were comparable across the three groups. Pain duration (CMSS score) was significantly higher in Group C than in the other two groups at each evaluation (P<0.001). There was also a significant difference in the improvement in pain duration between Group B and Group C (P<0.001) throughout the trial. There were no significant changes in pain severity (CMSS score) after the 3-month treatment in Group A and Group B (P>0.05). Secondary outcomes showed that pre-menstrual moxibustion (Group A) was as effective as menstrual-onset moxibustion (Group B) in relieving pain intensity (VAS score) and negative mood (SDS and SAS scores). CONCLUSION: Moxibustion appears as an effective treatment for PD. Pre-menstrual application is more effective than menstrual-onset application. TRIAL REGISTRATION CHICTRORGCN IDENTIFIER: ChiCTR-TRC-14004627.

3.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 36(1): 40-3, 2016 Jan.
Artículo en Chino | MEDLINE | ID: mdl-26955675

RESUMEN

OBJECTIVE: To observe the curative effect of porous tantalum rod and Gugutou Huaisiyu Capsule (GHC) for steroid-induced osteonecrosis of femoral head (SONFH). METHODS: A total 60 hips of 50 SONFH patients were randomly assigned to the treatment group and the control group according to grouping time, 25 in each group (30 hips). Patients in the control group were implanted with porous tantalum rod, while those in the treatment group additionally took GHC (5 pills each time, three time per day for 2 successive months; and then twice per day for 4 successive months). Then all patients were followed-up to observe Harris hip score. The curative effect and the femoral head survival time were assessed. RESULTS: A total of 49 patients (59 hips) were followed-up. The Harris hip score of the two groups at the final follow-up was significantly improved after treatment, with statistical difference when compared with before treatment (P < 0.01). Besides, it was higher in the treatment group than in the control group. The curative effect and the survival time were superior in the treatment group, with statistical difference when compared with the control group (P < 0.05). CONCLUSIONS: Porous tantalum rod combined GHC got better effect in treating SONFH. It could significantly improve the function of affected hips and prolong the survival time of femoral head.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Necrosis de la Cabeza Femoral/tratamiento farmacológico , Tantalio , Cápsulas , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/farmacología , Humanos , Prótesis e Implantes , Esteroides/efectos adversos
4.
Chin J Nat Med ; 12(12): 943-51, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25556066

RESUMEN

To develop a simple and highly sensitive high performance liquid chromatography with electrospray ionization mass spectrometric (LC-ESI-MS) method for the simultaneous determination of madecassoside and its major metabolite madecassic acid in rat plasma, and compare the pharmacokinetics of the two compounds in normal and collagen-induced arthritis (CIA) rats. Glycyrrhetinic acid was used as the internal standard (IS). Chromatographic separation was accomplished on an Inertsil ODS-3 column, using a gradient elution with the mobile phase composed of acetonitrile and water acidified with 0.1% (V/V) formic acid. Detection was achieved by ESI-MS under the negative selected ion monitoring (SIM) mode. In normal and CIA rats, madecassoside (30 mg·kg(-1)) was orally administered for 21 consecutive days from the day of arthritis onset. For madecassoside, the linear range was 10-1 000 ng·mL(-1) with the square regression coefficient (r) of 0.998 9, while for madecassic acid, the linear range was 10-500 ng·mL(-1) with the square regression coefficient (r) of 0.996 1. The lower limit of quantification was 10 ng·mL(-1) for both analytes. The intra- and inter-day precision ranged from 1.78% to 13.42% for madecassoside and 2.30% to 14.90% for madecassic acid, and the accuracy was between -0.95% and 6.30% for madecassoside and between -1.48% and 5.34% for madecassic acid. The average recoveries of madecassoside, madecassic acid and IS from spiked plasma samples were > 81%. The developed method was successfully applied to the pharmacokinetic study of madecassoside and madecassic acid in rats after an oral administration of madecassoside. During initial 7 days of dosing, the cmax and AUC of madecassoside were greatly decreased and Vd/F was markedly increased in CIA rats, and no significant difference was observed on the first day of dosing. In contrast, the T1/2, cmax and AUC of madecassic acid were significantly increased, and Ke of madecassic acid was greatly decreased in CIA rats compared with normal rats. Along with repeated administration of madecassoside, the differences of pharmacokinetic parameters of both madecassoside and madecassic acid between CIA and normal rats gradually subsided. The pharmacokinetic characteristics of both madecassoside and madecassic acid in rats were significantly altered by arthritis status, and the differences of pharmacokinetic parameters between arthritis and normal rats coincide with the severity of arthritis.


Asunto(s)
Artritis Reumatoide/tratamiento farmacológico , Centella/química , Fitoterapia , Extractos Vegetales/farmacocinética , Triterpenos/sangre , Triterpenos/farmacocinética , Animales , Antirreumáticos/sangre , Antirreumáticos/farmacocinética , Antirreumáticos/uso terapéutico , Área Bajo la Curva , Artritis Experimental/tratamiento farmacológico , Artritis Experimental/metabolismo , Artritis Reumatoide/metabolismo , Cromatografía Liquida/métodos , Colágeno , Femenino , Extractos Vegetales/sangre , Extractos Vegetales/uso terapéutico , Ratas Wistar , Valores de Referencia , Índice de Severidad de la Enfermedad , Espectrometría de Masa por Ionización de Electrospray/métodos , Espectrometría de Masas en Tándem/métodos , Triterpenos/uso terapéutico
5.
Ying Yong Sheng Tai Xue Bao ; 18(8): 1739-44, 2007 Aug.
Artículo en Chino | MEDLINE | ID: mdl-17974238

RESUMEN

With adjacent semi-moving dune as the control, this paper studied the effects of 5-, 10- and 22-year old Hedysarum fruticosum plantations on the nutrient status, microbial biomass, and enzyme activities at the soil depths 0-10, 10-20 and 20-30 cm. The results showed that with the establishment of H. fruticosum plantation on moving dune, soil C, N, P and K contents and biological activities increased obviously with the increasing age of the plantation, and the increment was much higher at 0-10 cm than at 10-20 and 20-30 cm. At 0-30 cm, soil C/N increased from 7.3 to 8.5, and microbial biomass C, N and P as well as the activities of urease, protease, saccharase, phosphomonoesterase, dehydrogenase, polyphenol oxidase and nitrate reductase all increased. Among the test enzyme activities, saccharase activity had the most significant increase, with its value at 0-10 cm being 49.7-284.5 times of the control. There were significant positive correlations between soil microbial biomass C, N and P and organic C, total N and total P, respectively, and between soil microbial biomass and enzyme activities.


Asunto(s)
Carbono/análisis , Fabaceae/fisiología , Microbiología del Suelo , Suelo/análisis , beta-Fructofuranosidasa/metabolismo , Biomasa , Ecosistema , Nitrógeno/análisis , Péptido Hidrolasas/metabolismo , Fósforo/análisis , Ureasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA